Four-ring bio-injected clean energy assets

"Pick off the star" less than three months of four Huan biological (000518, closing price of 6.22 Yuan) to find a new direction of investment, the company is optimistic about the film production and the recent large hot clean energy production. Interestingly, on the day of the four-ring bio-News (September 8), the company's shareholders sold the four-ring biological stock 10 million shares through the SSE trading platform.　　In August, the four-ring biological controlling shareholder Jiangyin Textile Textile Co., Ltd. (hereinafter referred to as Zhenhua textiles) only released or reduce the company's shares more than 5% of the announcement, the company holds four Huan biological 12.46% of the shares. The company is looking for new growth point four-ring biology September 9 announced that the company and Beijing Dahe Chau Group Co., Ltd. in cash to the Xinjiang Aidi New Energy Technology Co., Ltd. (hereinafter referred to as "Aidi new Energy" ) increased capital of 150 million yuan and 50 million yuan, Taiyuan City Pu Rong Kemao Limited to the patented technology intangible assets to increase the capital of 139 million yuan. The four-ring creature will hold a 44.12% stake in the new energy of Eddie. After the completion of the expansion of the new energy company has officially launched a total investment of 278 million yuan "national Science and Technology Support program 200,000 tons/year coal tar preparation clean fuel oil industry demonstration project". It is reported that Aidi new energy company's "National Science and Technology Support program 200,000 tons/year coal tar preparation clean fuel oil industry demonstration Project" project has been included in the "Eleven-Five" national Science and Technology Support Program organization implementation.　　The project adopts coal tar hydrogenation to high clean fuel oil, and plans to build a demonstration factory of high clean fuel oil from tar hydrogenation, with an annual output of 23760 tons of gasoline, 99000 tons of diesel, 15840 tons of crude phenol and 59400 tons of modified asphalt. Four-ring biology to the project, the company expects a very deep project construction period of 24 months, the project will reach production in the year, the estimated annual sales revenue of 775 million yuan, the average annual profit of 307 million yuan, investment profit margin of up to 88.31%.　　The company announced on the same day that another investment is less eye-catching, will invest 50 million yuan to set up a wholly-owned subsidiary Jiangyin four-Ring Investment Co., Ltd., engaged in film production, advertising agency and other business. Major shareholder or "King" four-ring biological investment project announcement, the company has large shareholders to reduce the four-ring life. The public information revealed that September 8 four-ring bio-stocks through the bulk trading platform for sale of 10 million shares, the transaction price of 6 yuan, sell sales department for Guotai Securities Wuxi People's Road securities business department. The company's semi-annual reports show that the top ten shareholders in the four-ring biology, the holding of more than 10 million shares of the only controlling shareholder Zhenhua Textile and Kunshan Venture Capital Co., Ltd.　　Taking into account the holding shareholder's August announcement of the proposed reduction, the sale of shares through the bulk trading platform is likely to be the new textile wool weaving. Prior to that, the first major shareholder vibration new wool textile held by the 128 million four-ring biological shares in the lifting of the restrictions on July 28, 2010, Vibration new wool textile immediately announced plans to reduce the company's total equity more than 5% of the stock. And the company injected excellentThe quality of assets for the holding of shareholders to reduce the best opportunity for the company to invest in new projects before the announcement of reduction, this has the opportunity to "King" suspicion. If the vibration of new wool textile holdings more than 5% of total equity, the four-ring biological equity will be extremely dispersed. It remains to be seen which side will eventually dominate the development of the company.